Litigation Details for Ahold USA, Inc. v. Allergan, PLC (f/k/a Actavis, PLC) (D. Mass. 2016)
✉ Email this page to a colleague
Ahold USA, Inc. v. Allergan, PLC (f/k/a Actavis, PLC) (D. Mass. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-07-19 |
Court | District Court, D. Massachusetts | Date Terminated | 2019-09-05 |
Cause | 15:1 Antitrust Litigation | Assigned To | Denise Jefferson Casper |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,649,180; 6,893,662; 8,580,302 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Ahold USA, Inc. v. Allergan, PLC (f/k/a Actavis, PLC)
Details for Ahold USA, Inc. v. Allergan, PLC (f/k/a Actavis, PLC) (D. Mass. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-07-19 | 1 | Complaint | on Delzicol is covered by U.S. Patent No. 6,649,180 (“the ’180 patent”), which expires April 13, 2020…on Delzicol is covered by U.S. Patent No. 6,649,180 (“the ’180 patent”), which expires April 13, 2020…the ’170 patent”) and U.S. Patent No. 5,541,171 (“the ’171 patent”). Both patents described a manner …Book patents that do not in fact claim the drug product because in reviewing patents and patent information…. The patent and drug regulation laws guaranteed Warner Chilcott a period of time until patent expiration | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |